Historical record - last NADAC effective date: 11/20/2019
Product Information
PROMETHEGAN 25 MG SUPPOSITORY is a generic product labeled by Cosette Pharmaceuticals, Inc., priced at $4.6629 per EA under NDC 00713052610. Its NADAC has been published 315 times since Nov 28, 2013.
FDA first approved this application on Feb 5, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Promethazine Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
25 mg/1
Manufacturer
Cosette Pharmaceuticals, Inc.NDC
00713052610
Classification
Generic
Dosage Form
SUPPOSITORY
Route
RECTAL
Effective Date
11/20/2019
Active Ingredients
PROMETHAZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA040428FDA Approved
2/5/2002
TE Code
AB
On Market Since
2/28/2002
Pharmacological Classes
Price Statistics
The NADAC for PROMETHEGAN 25 MG SUPPOSITORY has been published 315 times since Nov 28, 2013, and over the history we have for it it has declined 44.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.6629 per EA |
|---|---|
| All-time high | $9.2294 (May 13, 2015) |
| All-time low | $4.1368 (May 22, 2019) |
| Median price | $7.4787 |
| Average price | $7.1400 |
| Largest weekly change | -21.3% (May 22, 2019) |
| Weeks tracked | 315 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-44.0%
Last surveyed Dec 4, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 56% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PROMETHEGAN 25 MG SUPPOSITORY?
The current National Average Drug Acquisition Cost (NADAC) for PROMETHEGAN 25 MG SUPPOSITORY, manufactured by Cosette Pharmaceuticals, Inc., is $4.6629 per EA (NDC 00713052610), effective Dec 4, 2019.
How has the price of PROMETHEGAN 25 MG SUPPOSITORY changed over time?
Over the history we have for it, the NADAC for PROMETHEGAN 25 MG SUPPOSITORY has declined 44.0%. It has been tracked across 315 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PROMETHEGAN 25 MG SUPPOSITORY?
Since Nov 28, 2013, the NADAC for PROMETHEGAN 25 MG SUPPOSITORY has ranged from a low of $4.1368 (May 22, 2019) to a high of $9.2294 (May 13, 2015), with a median of $7.4787 per EA.
Are there cheaper alternatives to PROMETHEGAN 25 MG SUPPOSITORY?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PROMETHAZINE 25 MG SUPPOSITORY, is $2.0438 per EA — about 56% below PROMETHEGAN 25 MG SUPPOSITORY.
Who manufactures PROMETHEGAN 25 MG SUPPOSITORY?
PROMETHEGAN 25 MG SUPPOSITORY (NDC 00713052610) is labeled by Cosette Pharmaceuticals, Inc., and CMS classifies it as a generic product.